China · Delayed Price · Currency is CNY Zhende Medical Statistics
Total Valuation
Zhende Medical has a market cap or net worth of CNY 5.59 billion. The enterprise value is 5.74 billion.
| Market Cap | 5.59B |
| Enterprise Value | 5.74B |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | Jun 11, 2025 |
Share Statistics
Zhende Medical has 266.32 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 266.32M |
| Shares Outstanding | 266.32M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +3.54% |
| Owned by Insiders (%) | 5.42% |
| Owned by Institutions (%) | 10.92% |
| Float | 105.55M |
Valuation Ratios
The trailing PE ratio is 15.48 and the forward PE ratio is 14.29.
| PE Ratio | 15.48 |
| Forward PE | 14.29 |
| PS Ratio | 1.30 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.55, with an EV/FCF ratio of -14.32.
| EV / Earnings | 15.80 |
| EV / Sales | 1.34 |
| EV / EBITDA | 9.55 |
| EV / EBIT | 15.93 |
| EV / FCF | -14.32 |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.92 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.83 |
| Debt / FCF | -2.74 |
| Interest Coverage | 14.11 |
Financial Efficiency
Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is 3.20%.
| Return on Equity (ROE) | 6.41% |
| Return on Assets (ROA) | 2.79% |
| Return on Invested Capital (ROIC) | 3.20% |
| Return on Capital Employed (ROCE) | 5.46% |
| Revenue Per Employee | 549,707 |
| Profits Per Employee | 46,499 |
| Employee Count | 7,807 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.62 |
Taxes
In the past 12 months, Zhende Medical has paid 77.43 million in taxes.
| Income Tax | 77.43M |
| Effective Tax Rate | 17.14% |
Stock Price Statistics
The stock price has decreased by -2.19% in the last 52 weeks. The beta is 0.39, so Zhende Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -2.19% |
| 50-Day Moving Average | 20.62 |
| 200-Day Moving Average | 21.55 |
| Relative Strength Index (RSI) | 53.97 |
| Average Volume (20 Days) | 1,845,448 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhende Medical had revenue of CNY 4.29 billion and earned 363.01 million in profits. Earnings per share was 1.36.
| Revenue | 4.29B |
| Gross Profit | 1.42B |
| Operating Income | 360.10M |
| Pretax Income | 451.82M |
| Net Income | 363.01M |
| EBITDA | 596.01M |
| EBIT | 360.10M |
| Earnings Per Share (EPS) | 1.36 |
Balance Sheet
The company has 1.22 billion in cash and 1.10 billion in debt, giving a net cash position of 119.59 million or 0.45 per share.
| Cash & Cash Equivalents | 1.22B |
| Total Debt | 1.10B |
| Net Cash | 119.59M |
| Net Cash Per Share | 0.45 |
| Equity (Book Value) | 5.97B |
| Book Value Per Share | 21.43 |
| Working Capital | 1.41B |
Cash Flow
In the last 12 months, operating cash flow was 407.08 million and capital expenditures -807.57 million, giving a free cash flow of -400.50 million.
| Operating Cash Flow | 407.08M |
| Capital Expenditures | -807.57M |
| Free Cash Flow | -400.50M |
| FCF Per Share | -1.50 |
Margins
Gross margin is 33.04%, with operating and profit margins of 8.39% and 8.46%.
| Gross Margin | 33.04% |
| Operating Margin | 8.39% |
| Pretax Margin | 10.53% |
| Profit Margin | 8.46% |
| EBITDA Margin | 13.89% |
| EBIT Margin | 8.39% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.65, which amounts to a dividend yield of 3.10%.
| Dividend Per Share | 0.65 |
| Dividend Yield | 3.10% |
| Dividend Growth (YoY) | -48.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 42.76% |
| Buyback Yield | -0.17% |
| Shareholder Yield | 2.92% |
| Earnings Yield | 6.49% |
| FCF Yield | -7.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 8, 2020. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 8, 2020 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Zhende Medical has an Altman Z-Score of 3.1 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.1 |
| Piotroski F-Score | 7 |